Keying Che

No. 321, Zhongshan Road
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Artificial intelligence in predicting efficacy and toxicity of Immunotherapy: Applications, challenges, and future directions.

Artificial intelligence in predicting efficacy and toxicity of Immunotherapy: Applications, challenges, and future directions.

Journal: Cancer letters
Published: December 02, 2024

Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression.

Human myelocyte and metamyelocyte-stage neutrophils suppress tumor immunity and promote cancer progression.

Journal: Cell research
Published: November 20, 2024

IL-33 in cancer immunotherapy: Pleiotropic functions and biological strategies.

IL-33 in cancer immunotherapy: Pleiotropic functions and biological strategies.

Journal: Cytokine & growth factor reviews
Published: October 03, 2024

Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer.

Immunotherapies targeting the oncogenic fusion gene CLDN18-ARHGAP in gastric cancer.

Journal: EMBO molecular medicine
Published: August 28, 2023

Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer.

Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer.

Journal: EMBO molecular medicine
Published: December 18, 2022

Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers.

Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers.

Journal: The oncologist
Published: July 10, 2022

Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer.

Antigen-Specific T Cell Immunotherapy Targeting Claudin18.2 in Gastric Cancer.

Journal: Cancers
Published: May 01, 2022

DKK1 Promotes Tumor Immune Evasion and Impedes Anti-PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer.

DKK1 Promotes Tumor Immune Evasion and Impedes Anti-PD-1 Treatment by Inducing Immunosuppressive Macrophages in Gastric Cancer.

Journal: Cancer immunology research
Published: March 15, 2022

Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer.

Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer.

Journal: Journal of cancer research and clinical oncology
Published: November 17, 2021

ASO Author Reflections: Comparison of Three Lymph Node Staging Systems for Prognostic Evaluation of Resected Gastric Adenocarcinoma.

ASO Author Reflections: Comparison of Three Lymph Node Staging Systems for Prognostic Evaluation of Resected Gastric Adenocarcinoma.

Journal: Annals of surgical oncology
Published: June 07, 2021

Prognostic Nomograms Based on Three Lymph Node Classification Systems for Resected Gastric Adenocarcinoma: A Large Population-Based Cohort Study and External Validation.

Prognostic Nomograms Based on Three Lymph Node Classification Systems for Resected Gastric Adenocarcinoma: A Large Population-Based Cohort Study and External Validation.

Journal: Annals of surgical oncology
Published: March 24, 2021

Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.

Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.

Journal: Cancer medicine
Published: May 02, 2020
Showing 1-12 of 17

Last Updated: 09/26/2026